7. Department of Pathology

spinulosa-associated polyomavirus in a fatal case ofmyocarditis in a seven-month-old girl. Int J Clin1)

El Hajj H, Khalil B, Ghandour B, Nasr R, Shahine S,Ghantous A, Abdel-Samad R, Sinjab A, Hasegawa

2)

Pisano C, Bazarbachi A, Darwiche N: PreclinicalJ, Uehira T, Hagiwara S, Yajima K, Koizumi Y,

efficacy of the synthetic retinoid ST1926 for treating

Shirasaka T, Kojima Y, Nagai H, Yokomaku Y,

adult T-cell leukemia/lymphoma. Blood. 2014.

Shiozawa Y, Koibuchi T, Iwamoto A, Oka S,

124(13):2072-2080.

Hasegawa H, Okada S, Katano H: Classification of

Hasegawa S, Wakiguchi H, Okada S, Gui Kang Y,

AIDS-related lymphoma cases between 1987 andFujii N, Hasegawa M, Hasegawa H, Ainai A, Atsuta

2012 in Japan based on the WHO classification ofR, Shirabe K, Toda S, Wakabayashi-Takahara M,lymphomas, fourth edition. Cancer Med. 2014.

Morishima T, Ichiyama T: Cytokine profile of3(1):143-153.
8)

Inoue N, Ohbayashi C, Hasegawa H, Sata T,Cytokine. 2014. 69(2):206-210.

Fukayama M, Katano H: Evidence for human

Meguro S, Tomita M, Katsuki T, Kato K, Oh H,

herpesvirus-6B infection of regulatory T-cells in

Ainai A, Ito R, Kawai T, Itoh H, Hasegawa H:

acute

Plasma Antimicrobial Peptide LL-37 Level Is

immunocompetent adult with the drug reaction with

Inversely Associated with HDL Cholesterol Level in

eosinophilia and systemic symptoms syndrome: A

Patients with Type 2 Diabetes Mellitus. Int J

case report. J Clin Virol. 2014. 61(3):448-452.
9)

systemiclymphadenitis

inan

Katano H, Hishima T, Mochizuki M, Kodama Y,Yamada S, Fukuchi S, Hashimoto K, Fukui Y,Oyaizu N, Ota Y, Mine S, Igari T, Ajisawa A,Tsuda M, Kataoka M, Katano H, Inoue N: Guinea

Teruya K, Tanuma J, Kikuchi Y, Uehira T,

pig cytomegalovirus GP129/131/133, homologues

Shirasaka T, Koibuchi T, Iwamoto A, Oka S,

of human cytomegalovirus UL128/130/131A, areHasegawa H, Okada S, Yasuoka A: The prevalencenecessaryforJ

infectionofmonocytesandof opportunistic infections and malignancies inGenVirol.

2014.

95(Ptautopsied patients with human immunodeficiency6):1376-1382.

virus infection in Japan. BMC Infect Dis. 2014.

Yamada M, Katano H, Yotsumoto M, Hashimoto H,

14:229.

Muramatsu T, Shiotsuka M, Fukutake K, Kuroda M:10)

Kariya R, Taura M, Suzu S, Kai H, Katano H,

Unique expression pattern of viral proteins in human

Okada S: HIV protease inhibitor Lopinavir induces

herpesvirus 8-positive plasmablastic lymphoma: aapoptosis of primary effusion lymphoma cells via

casesuppression of NF-kappaB pathway. Cancer Lett.

report.

IntJClinExpPathol.

2014.

2014. 342(1):52-59.

7(9):6415-6418.
6)

Mine S, Suzuki K, Sato Y, Fukumoto H, Kataoka M,

bronchial asthma during seasonal H1N1 infection.

macrophages.

5)

Ota Y, Hishima T, Mochizuki M, Kodama Y,
Moritani S, Oyaizu N, Mine S, Ajisawa A, Tanuma

Endocrinol. 2014. 2014:703696.
4)7)

H, Jabbour M, Hall WW, Zaatari G, Dbaibo G,

bronchoalveolar lavage fluid from a mouse model of3)

Exp Pathol. 2014. 7(8):5308-5312.

Tsuzuki S, Fukumoto H, Mine S, Sato N, Mochizuki

11)

Goto H, Kojima Y, Matsuda K, Kariya R, Taura M,M, Hasegawa H, Sekizuka T, Kuroda M, Matsushita

Kuwahara K, Nagai H, Katano H, Okada S: Efficacy

T,of anti-CD47 antibody-mediated phagocytosis withKatano

H:Detectionoftrichodysplasia12)

macrophages against primary effusion lymphoma.

major role in in vivo replication of emerging H7N9

Eur J Cancer. 2014. 50(10):1836-1846.

and seasonal influenza viruses.

Endo A, Watanabe K, Ohye T, Suzuki K, Matsubara88(10):5608-5616.

T, Shimizu N, Kurahashi H, Yoshikawa T, Katano H,13)

Hatta M, Hanson A, McBride R, Burke DF,

Molecularviral

Takahashi K, Fukuyama S, Tomita Y, Maher EA,

activation from chromosomally integrated human

Watanabe S, Imai M, Neumann G, Hasegawa H,

herpesvirus 6A in a patient with X-linked severe

Paulson JC, Smith DJ, Kawaoka Y: Circulating

combined immunodeficiency. Clin Infect Dis. 2014.

avian influenza viruses closely related to the 1918

59(4):545-548.

virus have pandemic potential.

Koma T, Yoshimatsu K, Nagata N, Sato Y, Shimizu

2014. 15(6):692-705.

Arikawa

andvirologicalevidenceofJ:

Neutrophil

pulmonaryvascularoccurrenceofdepletion

hyperpermeability

Cell Host Microbe.

Moritake H, Kamimura S, Nunoi H, Nakayama H,
Suminoe A, Inada H, Inagaki J, Yanai F, Okamoto Y,

andShinkoda Y, Shimomura M, Itonaga N, Hotta N,

byHidaka Y, Ohara O, Yanagimachi M, Nakajima N,

hantavirus infection in C.B-17 SCID mice. J Virol.

Okamura J, Kawano Y: Clinical characteristics and2014. 88(13):7178-7188.

genetic analysis of childhood acute lymphoblastic

pulmonary

Iwata-Yoshikawa

N,

edema

Uda

A,

causedSuzuki

leukemia with hemophagocytic lymphohistiocytosis:

T,

Tsunetsugu-Yokota Y, Sato Y, Morikawa S, TashiroaM, Sata T, Hasegawa H, Nagata N: Effects ofKyushu-Yamaguchi Children's Cancer Study Group.

Toll-like

Int J Hematol. 2014. 100(1):70-78.

withreceptor

stimulation

UV-inactivatedon

eosinophilic

severeretrospective

studybytheHiraki T, Yoshimitsu M, Suzuki T, Goto Y, Higashi
M, Yokoyama S, Tabuchi T, Futatsuki T, Nakamura

syndrome-related coronavirus vaccine. J Virol. 2014.

K, Hasegawa H, Saijo M, Kakihana Y, Arima N,

88(15):8597-8614.

Yonezawa S: Two autopsy cases of severe fever with

Nagata N, Saijo M, Kataoka M, Ami Y, Suzaki Y,

thrombocytopenia syndrome(SFTS) in Japan: A

Sato Y, Iwata-Yoshikawa N, Ogata M, Kurane I,

pathognomonic histological feature and unique

Morikawa S, Sata T, Hasegawa H: Pathogenesis ofcomplication

fulminant monkeypox with bacterial sepsis after64(11):569-575.

infectionwithacute

19)

Japanese

respiratory

experimental16)

18)

suppresses

infiltration in lungs of BALB/c mice immunized

15)

Watanabe T, Zhong G, Russell CA, Nakajima N,Inoue N, Imai K, Takagi M, Morio T, Mizutani S:K, Yasuda SP, Amada T, Nishio S, Hasegawa H,14)

17)

J Virol. 2014.

WestAfrican20)

ofSFTS.

PatholInt.

2014.

van Riet E, Ainai A, Suzuki T, Kersten G, Hasegawa

monkeypox virus in a cynomolgus monkey. Int J

H: Combatting infectious diseases; nanotechnology

Clin Exp Pathol. 2014. 7(7):4359-4370

as a platform for rational vaccine design. Adv Drug

Sakai K, Ami Y, Tahara M, Kubota T, Anraku M,Deliv Rev. 2014. 74:28-34.

Abe M, Nakajima N, Sekizuka T, Shirato K, Suzaki21)

Takahashi T*, Maeda K*, Suzuki T*, Ishido A,Y, Ainai A, Nakatsu Y, Kanou K, Nakamura K,

Shigeoka T, Tominaga T, Kamei T, Honda M,

Suzuki T, Komase K, Nobusawa E, Maenaka K,

Ninomiya D, Sakai T, Senba T, Kaneyuki S,Kuroda M, Hasegawa H, Kawaoka Y, Tashiro M,Sakaguchi S, Satoh A, Hosokawa T, Kawabe Y,Takeda M: The host protease TMPRSS2 plays aKurihara S, Izumikawa K, Kohno S, Azuma T,

Suemori K, Yasukawa M, Mizutani T, Omatsu T,

complete genome sequences of HCV genotype 6

Umeki K, Saito T, Fukushima K, Nakajima K,

from Vietnam including new subtypes 6xb and 6xc.

Yoshikawa T, Tani H, Fukushi S, Fukuma A, Ogata

Virology. 2014. 468-470:172-177.

Fukumoto H, Sato Y, Hasegawa H, Yamagishi T,Oishi K, Kurane I, Morikawa S, Saijo M: The firstidentification and retrospective study of Severe
Fever with Thrombocytopenia Syndrome in Japan. J
Infect Dis. 2014. 209(6):816-827. *Contributed
equally to this work
Makino Y, Suzuki T, Hasebe R, Kimura T, Maeda A,Takahashi H, Sawa H: Establishment of tracking
system for West Nile virus entry and evidence of
microtubule involvement in particle transport. J
Virol Methods. 2014. 195:250-257.
23)

Utachee P, Isarangkura-na-ayuthaya P, Tokunaga K,Ikuta K, Takeda N, Kameoka M: Impact of aminoacid substitutions in the V2 and C2 regions ofhuman immunodeficiency virus type 1 CRF01_AE
envelope glycoprotein gp120 on viral neutralizationsusceptibility to broadly neutralizing antibodies
specific for the CD4 binding site. Retrovirology.
2014. 11:32.

24)

Freitas N, Abe K, Cunha C, Menne S, Gudima SO:
Support of the infectivity of hepatitis delta virus
particles by the envelope proteins of different
genotypes of hepatitis B virus. J Virol. 2014.
88(11):6255-67.

25)

Tran H, Yu ML, Dai CY, Lin IL, Yeh ML, Chuang
WL, Abe K: Novel quasi-subgenotype D2 ofhepatitis B virus identified in Taiwanese aborigines.
Virus Genes. 2014. 49(1):30-37.

26)

Li C, Pham VH, Abe K, Lu L: Nine additional

Katayama Y, Miyahara M, Ijuin M, Doi K, Okuda M,M, Shimojima M, Nakajima N, Nagata N, Katano H,

22)

27)

Li C, Yuan M, Lu L, Lu T, Xia W, Pham VH, Vo
AXD, Nguyen MH, Abe K: The genetic diversity
and evolutionary history of hepatitis C virus inVietnam. Virology. 2014. 468-470:197-206.